Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ

$11.69

$+0.34

(+2.98%)

Regular Market

Enanta Pharmaceuticals, Inc. (ENTA) Live Price Chart

Last updated: ⁦2026-10-20 15:54:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Enanta Pharmaceuticals, Inc. (ENTA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $11.69, with a market capitalization of $323.29M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.20 to $17.15. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$323.29M
Open	$11.43
Day's High	$127.77
Day's Low	$4.09
Previous Close	$11.41
Volume	51.64K
Average Volume	234.60K
P/E Ratio	--
52-Week High	$17.15
52-Week Low	$10.20
Dividend Yield	--
Earnings Date	--

Enanta Pharmaceuticals, Inc. (ENTA) Stock Price Today

Enanta Pharmaceuticals, Inc. (ENTA) is currently trading at $11.69 as of 2026-10-20 15:53:00, up 2.49% ($0.28) from the previous close of $11.41

During today's regular trading session, ENTA has traded between $4.09 and $127.77, with a trading volume of 51.64K shares. The current price is near the lower end of today's range.

Enanta Pharmaceuticals, Inc. (ENTA) 7-Day Stock Price Change

Over the past seven days, Enanta Pharmaceuticals, Inc. (ENTA) moved from $12.50 to $11.69, representing a decline of 6.45% ($0.81).

The stock traded between $10.95 and $12.64 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 199.12 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ENTA 52-Week Price Position

Position in Range: 21.5%

52W Low$10.20

52W High$17.15

ENTA is currently trading at $11.69, placing it 21.5% of the way from its 52-week low of $10.20 to its 52-week high of $17.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Enanta Pharmaceuticals, Inc. (ENTA)?

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Enanta Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	120
Exchange	NASDAQ
Company Website	https://www.enanta.com

How to Buy Enanta Pharmaceuticals, Inc. (ENTA) Stock on MEXC

Eligible investors can buy real shares of Enanta Pharmaceuticals, Inc. (ENTA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ENTA and Place Your Order

Open the RealStocks trading page and search for ENTA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Enanta Pharmaceuticals, Inc. (ENTA) stock price today?

Enanta Pharmaceuticals, Inc. (ENTA) is currently trading at $ 11.69, up 2.49% ($0.28) from the previous close of $ 11.41. Intraday prices update in real time during regular trading hours.

2.Is ENTA stock going up or down today?

As of 2026-10-20 15:53:00, ENTA is trading at $ 11.69, up 2.49% ($0.28) from its previous close of $ 11.41. The stock has traded between $ 4.09 and $ 127.77 during today’s regular session. Past price movements do not guarantee future results.

3.What is ENTA pre-market price?

As of 2026-10-20 15:53:00, ENTA is trading at $ 11.15 in pre-market trading, down 2.28% ($0.26) from the previous close of $ 11.41. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ENTA after-hours price?

As of 2026-10-20 15:53:00, ENTA is trading at $ 11.41 in after-hours trading, down 0.04% ($0.01) from the regular-session close of $ 11.41. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ENTA stock trading now?

ENTA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ENTA sit relative to its 52-week high and low?

Over the past 52 weeks, ENTA has traded between a low of $ 10.20 and a high of $ 17.15. At $ 11.69, the stock is positioned 21.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Enanta Pharmaceuticals, Inc. in?

Enanta Pharmaceuticals, Inc. (ENTA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Enanta Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Enanta Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 323.29M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ENTA valued in terms of P/E ratio and EPS?

ENTA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.17. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Enanta Pharmaceuticals, Inc. pay a dividend?

Enanta Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.